Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-07-18Clinical Trial Update: Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC) [EARLY_Phase 1]
The clinical trial evaluating a mature dendritic cell vaccine for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-14Clinical Trial Update: AZD9291 US Expanded Access Program
A US expanded access program for AZD9291 (osimertinib) in EGFR T790M mutation-positive non-small cell lung cancer is no longer available.
-
CLINICAL_TRIALS withdrawal · 2016-07-06Clinical Trial Update: Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of gemcitabine hydrochloride and carboplatin with or without MK-0646 for first-line treatment of stage IIIB or IV non-small …
-
CLINICAL_TRIALS withdrawal · 2016-06-24Clinical Trial Update: Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations [EARLY_Phase 1]
The PARTIST trial evaluating personalized adaptive radiation therapy with individualized systemic targeted therapy for locally advanced non-…
-
CLINICAL_TRIALS withdrawal · 2016-05-17Clinical Trial Update: Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial of rociletinib in non-small cell lung cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-05-12Clinical Trial Update: Electromagnetic Navigational Bronchoscopy Vs. Transthoracic Needle Biopsy for the Sampling of Peripheral Lung Nodules [Phase 2]
A Phase 2 clinical trial comparing Electromagnetic Navigational Bronchoscopy versus Transthoracic Needle Biopsy for sampling peripheral lung…
-
CLINICAL_TRIALS withdrawal · 2016-03-07Clinical Trial Update: The Effect Of Aspirin On Survival in Lung Cancer [Phase 3]
A Phase 3 trial evaluating aspirin's effect on survival in non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-11Clinical Trial Update: Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of talazoparib in combination with gemcitabine and cisplatin for advanced solid tumors has been withdrawn.
-
EMA withdrawal · 2016-01-14EMA Withdrawn: Nivolumab BMS (nivolumab) — Bristol-Myers Squibb Pharma EEIG
EMA withdrawn nivolumab (BMS) for non-small cell lung carcinoma; product withdrawal decision in 2015.
-
CLINICAL_TRIALS withdrawal · 2015-12-14Clinical Trial Update: Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 study evaluating motesanib in combination with paclitaxel and carboplatin for advanced non-squamous non-small cell lung cancer has…
-
CLINICAL_TRIALS withdrawal · 2015-11-20Clinical Trial Update: Feasibility of Mutational Analysis of Non-Small Cell Lung Cancer (NSCLC) Using Low-volume Lung Aspirates
The trial evaluating mutational analysis of non-small cell lung cancer using low-volume lung aspirates has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-28Clinical Trial Update: A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel [Phase 2]
A Phase 2 clinical trial evaluating whether EGFR status by FISH can predict response to cetuximab, carboplatin, and paclitaxel in non-small …
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating enzastaurin with carboplatin and gemcitabine, with or without bevacizumab, for recurrent stage IIIB or IV non-sma…
-
CLINICAL_TRIALS withdrawal · 2015-10-02Clinical Trial Update: Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial of vandetanib (ZD6474) combined with fulvestrant (Faslodex) in non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-30Clinical Trial Update: Time Trends in Waiting Times of NSCLC Patients.
A clinical trial evaluating the time trends in waiting times for non-small cell lung cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-16Clinical Trial Update: Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung Cancer [NA]
A clinical trial evaluating stereotactic radiosurgery followed by wedge resection for early-stage peripheral non-small cell lung cancer has …
-
CLINICAL_TRIALS withdrawal · 2015-09-02Clinical Trial Update: A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating ranpirnase (Onconase) in combination with pemetrexed and carboplatin for non-squamous non-small cell lung cancer …
-
CLINICAL_TRIALS withdrawal · 2015-08-27Clinical Trial Update: Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED) [Phase 3]
A Phase 3 trial evaluating lonafarnib with paclitaxel and carboplatin in non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2015-08-20Clinical Trial Update: Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors [Phase 1]
Phase 1 safety study of daily combination therapy with XL647 and XL147 in adults with solid tumors; the study has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-19Clinical Trial Update: Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial of nimotuzumab with cisplatin and docetaxel for advanced non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-13Clinical Trial Update: Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib [Phase 2]
A Phase 2 trial evaluating pemetrexed disodium with carboplatin or cisplatin, with or without erlotinib, for stage IV non-small cell lung ca…
-
CLINICAL_TRIALS withdrawal · 2015-07-08Clinical Trial Update: T790M Mutation Positive 2nd Line STandard of cAre Registry
ClinicalTrials.gov entry for a T790M mutation-positive, second-line standard of care registry in non-small cell lung cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-24Clinical Trial Update: A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 safety and efficacy trial of Amplimexon in combination with Taxotere for metastatic non-small cell lung cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
A Phase 1 trial of sublingual Anvirzel for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-08Clinical Trial Update: Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating Tarceva (erlotinib) in combination with AT-101 for advanced non-small cell lung cancer has been withdrawn.